Conference Coverage
Conference Coverage
Adding pembrolizumab to cisplatin-based CRT shows promise in HPV+ head and neck cancers
Pembrolizumab plus cisplatin-based chemoradiotherapy shows promise for locally advanced, HPV-positive head and neck squamous cell carcinoma.
Conference Coverage
Refractory immune-mediated colitis: Fecal transplant may be the answer
WASHINGTON – FMT shows promise for the treatment of refractory immune checkpoint inhibitor–associated colitis.
Conference Coverage
‘Organoid technology’ poised to transform cancer care
BOSTON – Clinical trials may one day be conducted in a petri dish.
Conference Coverage
‘Watch and wait’ good for most – but not all – rectal cancers
BOSTON – Who needs upfront surgery?
Video
How to slash colorectal surgery infection rates
BOSTON – Change perioperative routines.
Conference Coverage
Vitamin D, fish oil circling the drain for primary prevention
CHICAGO – Massive VITAL trial shows the popular supplements don’t lower cardiovascular or cancer risk.
Conference Coverage
Capmatinib active against NSCLC with MET exon 14 mutations
MUNICH – Patients with MET exon 14–skipping mutations, but not MET gene amplification, had a high response rate to capmatinib.
Conference Coverage
Researchers seek more sickle cell drug research
BETHESDA, MD – While there are experimental treatments such as ...
Conference Coverage
Zanubrutinib looks ‘robust’ in Waldenström macroglobulinemia
Phase 1 data shows a high overall response rate to the BTK inhibitor.
Conference Coverage
Antigen profiling may help prevent transfusion complications
BETHESDA, MD. – Extended red cell antigen profiling before initial transfusion can help avoid complications in highly transfused populations.
Conference Coverage
Variant not linked to CLL in Southeast Europe
DUBROVNIK, CROATIA – The PTPN22 R620W polymorphism was not associated with CLL in patients from Southeast Europe.